Since 2022, former healthcare executive Kathleen “Kate” Goonan has worked with the anti-trans groups Society for Evidence-Based Gender Medicine (SEGM) and Genspect to advance restrictions on gender-affirming care for trans youth. At SEGM, Goonan attended an April 25, 2022 meeting with the U.S. Department of Health and Human Services, where the group argued against “hormonal and surgical interventions that have not been proven to be effective” and described gender-affirming care as “a euphemism for a highly invasive treatment protocol for minors” (in “Remarks HHS meeting_2022”). Goonan later appeared as a panel moderator at SEGM’s October 9-12 “International Perspectives Conference” in New York, an alternative conference that originated when the group’s proposed panels at the American Academy of Child and Adolescent Psychiatry (AACAP) were all rejected.
Within Genspect, “Dr. Kate” has played a central role in their “Parent Advocacy Programme” since 2022, offering to “liaise with professionals” for unaccepting parents of trans youth for “a small fee”. According to Genspect, this advocacy consists of contacting the child’s “teachers and school counsellors to therapists, paediatricians, mental health workers and other clinicians” to “put forward a different point of view about how best to support gender-questioning youth”. One testimonial from parents in the UK describes their family’s circumstances:
Our daughter’s school allowed her to socially transition without parental consent or knowledge. We have had incredible support from Genspect and that’s how Kate was introduced to us to be our advocate.